Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Reiman

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Neurology|February 18, 2011
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesR J Caselli, A C Dueck, D E C Locke, et al.
Neurobiology of Aging|October 18, 2005
Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairmentS C Johnson, T W Schmitz, C H Moritz, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
The Journal of Prevention of Alzheimer'S Disease|February 14, 2019
Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian KindredJ T Fuller, A Cronin-Golomb, J R Gatchel, et al.
Molecular Psychiatry|September 2, 2015
Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's diseaseM A Lalli, B M Bettcher, M L Arcila, et al.
Molecular Psychiatry|March 18, 2015
A novel Alzheimer disease locus located near the gene encoding tau proteinG Jun, C A Ibrahim-Verbaas, M Vronskaya, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Neurology|February 18, 2011
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesR J Caselli, A C Dueck, D E C Locke, et al.
Neurobiology of Aging|October 18, 2005
Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairmentS C Johnson, T W Schmitz, C H Moritz, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
The Journal of Prevention of Alzheimer'S Disease|February 14, 2019
Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian KindredJ T Fuller, A Cronin-Golomb, J R Gatchel, et al.
Molecular Psychiatry|September 2, 2015
Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's diseaseM A Lalli, B M Bettcher, M L Arcila, et al.
Molecular Psychiatry|March 18, 2015
A novel Alzheimer disease locus located near the gene encoding tau proteinG Jun, C A Ibrahim-Verbaas, M Vronskaya, et al.
Pageof 7